- Home
- AVDL vs DQ Comparison
AVDL vs DQ Comparison
Compare AVDL & DQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVDL
- DQ
- Stock Information
- Founded
- AVDL 2015
- DQ 2006
- Country
- AVDL Ireland
- DQ China
- Employees
- AVDL N/A
- DQ N/A
- Industry
- AVDL Biotechnology: Pharmaceutical Preparations
- DQ Semiconductors
- Sector
- AVDL Health Care
- DQ Technology
- Exchange
- AVDL Nasdaq
- DQ Nasdaq
- Market Cap
- AVDL 1.4B
- DQ 1.4B
- IPO Year
- AVDL 1996
- DQ 2010
- Fundamental
- Price
- AVDL $11.66
- DQ $18.81
- Analyst Decision
- AVDL Strong Buy
- DQ Hold
- Analyst Count
- AVDL 6
- DQ 5
- Target Price
- AVDL $24.00
- DQ $20.31
- AVG Volume (30 Days)
- AVDL 1.7M
- DQ 2.1M
- Earning Date
- AVDL 11-12-2024
- DQ 10-30-2024
- Dividend Yield
- AVDL N/A
- DQ N/A
- EPS Growth
- AVDL N/A
- DQ N/A
- EPS
- AVDL N/A
- DQ N/A
- Revenue
- AVDL $138,160,000.00
- DQ $1,310,019,000.00
- Revenue This Year
- AVDL $533.23
- DQ N/A
- Revenue Next Year
- AVDL $73.08
- DQ $47.79
- P/E Ratio
- AVDL N/A
- DQ N/A
- Revenue Growth
- AVDL 1523.50
- DQ N/A
- 52 Week Low
- AVDL $10.41
- DQ $13.62
- 52 Week High
- AVDL $19.09
- DQ $30.85
- Technical
- Relative Strength Index (RSI)
- AVDL 40.12
- DQ 43.00
- Support Level
- AVDL $10.41
- DQ $18.27
- Resistance Level
- AVDL $16.66
- DQ $20.67
- Average True Range (ATR)
- AVDL 0.88
- DQ 1.22
- MACD
- AVDL -0.31
- DQ -0.44
- Stochastic Oscillator
- AVDL 20.00
- DQ 9.34
About AVDL Avadel Pharmaceuticals plc
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.
About DQ DAQO New Energy Corp.
Daqo New Energy Corp is a polysilicon manufacturer based in China. The company manufactures and sells high-purity polysilicon to manufacturers who use it to make ingots, cells, and modules for solar power solutions. The polysilicon is packaged to meet crucible stacking, pulling, and solidification needs. All of the company's revenues come from the People's Republic of China.